scholarly article | Q13442814 |
P50 | author | Salim Yusuf | Q2214381 |
Christopher B. Granger | Q62050240 | ||
Karl Swedberg | Q65769660 | ||
Brian Claggett | Q90483213 | ||
Marc A Pfeffer | Q114321706 | ||
Hicham Skali | Q37838150 | ||
Davide Castagno | Q51816537 | ||
Pardeep S. Jhund | Q52145742 | ||
John McMurray | Q56633150 | ||
P2093 | author name string | Scott D Solomon | |
Ali Vazir | |||
P2860 | cites work | Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study | Q28291971 |
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme | Q34246882 | ||
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial | Q34246891 | ||
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial | Q34246898 | ||
Mode of death in heart failure: findings from the ATLAS trial | Q35580685 | ||
Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies | Q35771528 | ||
Elevated heart rate: a major risk factor for cardiovascular disease | Q36035810 | ||
Resting heart rate in cardiovascular disease | Q36919145 | ||
Is heart rate important for patients with heart failure in atrial fibrillation? | Q38222202 | ||
Predictors of mortality and morbidity in patients with chronic heart failure | Q39361079 | ||
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial | Q42923271 | ||
Resting heart rate pattern during follow-up and mortality in hypertensive patients | Q43206150 | ||
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) stu | Q43749481 | ||
Temporal changes in resting heart rate and deaths from ischemic heart disease | Q43920198 | ||
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Q44588075 | ||
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial | Q46616032 | ||
Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. | Q48164763 | ||
Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure | Q57396205 | ||
P433 | issue | 11 | |
P304 | page(s) | 669-675 | |
P577 | publication date | 2014-11-02 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program | |
P478 | volume | 36 |
Q47182647 | Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study |
Q47647624 | Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. |
Q92740551 | Association of patient-reported outcomes and heart rate trends in heart failure: a report from the Chiron project |
Q64091025 | Association of resting heart rate and its change with incident cardiovascular events in the middle-aged and older Chinese |
Q88723395 | Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy |
Q90203537 | Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial |
Q47120245 | Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors |
Q92462108 | Heart rate and blood pressure monitoring in heart failure |
Q48132218 | Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis. |
Q89547585 | Inter- and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: Retrospective, longitudinal cohort study of 92,457 adults |
Q47794681 | Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study |
Q90095011 | Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation? |
Q92065869 | Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction |
Q41899817 | Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation |
Q57296974 | Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across Left Ventricular Ejection Fraction Spectrum |
Q37643822 | Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study |
Q89451975 | Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study |
Q90299460 | The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction |
Q85404538 | [Chronic heart failure : current guideline recommendations and innovations] |
Q85512879 | [Update on therapy of chronic heart failure. Innovations and studies from last year] |